Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Impact of lineage plasticity and heterogeneity on cancer therapies

Recapitulating human cancer through organoid models: Therapeutic implications of cellular heterogeneity 

Date

16 Sep 2021

Session

Impact of lineage plasticity and heterogeneity on cancer therapies

Topics

Cytotoxic Therapy;  Targeted Therapy;  Cancer Biology;  Translational Research

Tumour Site

Colon and Rectal Cancer

Presenters

Jeanine Roodhart

Authors

J. Roodhart

Author affiliations

  • Medical Oncology, UMC-University Medical Center Utrecht, 3584 CX - Utrecht/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Martijn Lolkema

Session: Impact of lineage plasticity and heterogeneity on cancer therapies

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.